2026-01-02 - Analysis Report
Okay, here's a comprehensive analysis of Salesforce (CRM) based on the data provided.

**1. Return Rate Comparison (CRM vs. S&P 500)**

*   **Company Overview:** Salesforce Inc. is a leading provider of cloud-based software and services focused on customer relationship management (CRM).
*   **CRM Cumulative Return:** -6.74%
*   **S&P 500 (VOO) Cumulative Return:** 105.07%
*   **Divergence:** -111.8 (Relative Divergence: 8.0)

**Analysis:** CRM has significantly underperformed the S&P 500 over the tracked period, resulting in a divergence of -111.8%. The relative divergence of 8.0 indicates that the current divergence is near the *bottom* of its historical range, suggesting the underperformance is near its worst point compared to the S&P 500 over the given timeframe.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD  | Alpha | Beta | Cap(B) |
|------------|--------|------|-------|------|--------|
| 2016-2018  | 101.0% | 73.2% | 72.0% | 1.4  | 130.4  |
| 2017-2019  | 106.0% | 73.2% | 64.0% | 1.4  | 154.8  |
| 2018-2020  | 95.0%  | 76.4% | 63.0% | 1.1  | 211.8  |
| 2019-2021  | 67.0%  | 76.4% | -9.0% | 1.1  | 241.9  |
| 2020-2022  | -27.0% | 80.0% | -46.0% | 1.2  | 126.2  |
| 2021-2023  | 17.0%  | 87.2% | -12.0% | 1.4  | 250.5  |
| 2022-2024  | 44.0%  | 85.3% | 13.0% | 1.4  | 318.3  |
| 2023-2025  | 58.0%  | 76.7% | -10.0% | 1.2  | 252.2  |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate shows significant volatility.  Early periods (2016-2019) had exceptional growth, followed by periods of decline or modest growth.
*   **MDD:**  Maximum Drawdown is consistently high, indicating significant price volatility and risk.
*   **Alpha:** Alpha, representing risk-adjusted outperformance, has been negative in recent periods (2019-2025), suggesting underperformance relative to its risk. Prior to that, Alpha was strongly positive.
*   **Beta:**  Beta is consistently above 1, indicating that CRM's price is more volatile than the market (S&P 500).
*   **Cap(B):** Market Cap (in Billions) shows overall growth in the company's size, although this is not directly related to stock performance.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 264.91
*   **Previous Close:** 265.92
*   **Change:** -0.38
*   **5-day SMA:** 265.68
*   **20-day SMA:** 259.8965
*   **60-day SMA:** 249.0623

**Analysis:**  The price closed slightly lower than the previous day. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA. This suggests a short-term upward trend, but the proximity of the SMAs suggests the trend may not be very strong.

**3. RSI, PPO, and Divergence Analysis**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 51.39
*   **PPO:** 0.11
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 1.4 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** 0.0

**Analysis:**

*   **MRI:** The MRI indicates a medium level of risk, suggesting a moderately favorable investment environment.
*   **RSI:** An RSI of 51.39 is near neutral, suggesting neither overbought nor oversold conditions.
*   **PPO:** A PPO of 0.11 is a relatively small value.
*   **Hybrid Signal:** The hybrid signal recommends buying with 90% of available cash, suggesting a bullish outlook.
*   **Recent Divergence Change:** The recent increase in relative divergence indicates short-term positive momentum.
*   **Expected Return:** The expected return of 0.0% is concerning, as it suggests no anticipated outperformance compared to the S&P 500 over a long-term investment horizon.

**4. Recent News & Significant Events**

*   **Positive Headlines:** Several headlines are positive, suggesting potential for a stock rebound. Examples include:
    *   "Salesforce Earnings Might Have Been Good Enough to End Its Stock’s 3 Quarter Losing Streak"
    *   "Salesforce Stock Now 27% Cheaper, Time To Buy"
    *   "Salesforce: Top Pick For 2026, The Death Of SaaS Has Been Overstated"
*   **Partnership Expansion:** The expanded partnership with USDOT is a positive indicator of business growth and expansion into new sectors.
*   **Analyst Interest:** Headlines discussing price predictions and forecasts indicate continued interest from analysts, which can influence investor sentiment.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.64)
*   **Target Price:** Average: 330.06 (Upside potential from current price)
*   **Recent Rating Changes:** None reported ( → )

**Analysis:**  The analyst consensus is a "Buy," and the average target price suggests significant upside potential. The lack of recent rating changes suggests a stable outlook from analysts.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-12-04 | 2.20 | 10.26 B$   |
| 2025-09-04 | 1.97 | 10.24 B$   |
| 2025-05-29 | 1.61 | 9.83  B$   |
| 2024-12-04 | 1.60 | 9.44  B$   |
| 2025-12-04 | 1.60 | 9.44 B$    |

**Analysis:** EPS and Revenue have generally been increasing over the analyzed quarters. The EPS showing 2.20 on 2025-12-04 suggests recent strong performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-10-31   | $10.26B   | 78.02%        |
| 2025-07-31   | $10.24B   | 78.10%        |
| 2025-04-30   | $9.83B    | 76.96%        |
| 2025-01-31   | $9.99B    | 77.81%        |
| 2024-10-31   | $9.44B    | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-10-31   | $60.02B   | 3.48%  |
| 2025-07-31   | $61.33B   | 3.08%  |
| 2025-04-30   | $60.67B   | 2.54%  |
| 2025-01-31   | $61.17B   | 2.79%  |
| 2024-10-31   | $58.52B   | 2.61%  |

**Analysis:**

*   **Revenue:** Revenue shows a consistent upward trend.
*   **Profit Margin:** Profit margins are high and relatively stable, indicating strong operational efficiency.
*   **Equity:** Equity fluctuates but remains substantial.
*   **ROE:** ROE has improved recently, showing increased profitability relative to equity.

**7. Comprehensive Analysis (Summary)**

*   **Underperformance:** CRM has significantly underperformed the S&P 500, but the relative divergence suggests this underperformance may be near its worst point.
*   **Volatility:**  CRM is more volatile than the overall market (Beta > 1).
*   **Recent Positive Momentum:** Recent news headlines, a hybrid trading signal, and short-term divergence changes suggest a potential for a rebound. The most recent earnings were strong.
*   **Analyst Confidence:** Analyst consensus is a "Buy" with a significant upside target price.
*   **Strong Fundamentals:** Revenue and profit margins are strong and growing. Equity is substantial.
*   **Expected Return:** The expected return of 0% is a significant concern and contradicts with the generally optimistic outlook from other metrics. This might be a key data point to further investigate.

**Overall Conclusion:**

The data paints a mixed picture. CRM has underperformed the market significantly, but recent indicators suggest a potential turnaround. Strong fundamentals, positive analyst sentiment, and encouraging news headlines provide reasons for optimism. However, high volatility and a reported 0% expected return present risks that should be carefully considered. The mismatch between the expected return and other indicators deserves further scrutiny.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.